1. Home
  2. KRYS vs NEU Comparison

KRYS vs NEU Comparison

Compare KRYS & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$327.51

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Logo NewMarket Corp

NEU

NewMarket Corp

N/A

Current Price

$917.14

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KRYS
NEU
Founded
2015
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.6B
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
KRYS
NEU
Price
$327.51
$917.14
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $392.11
N/A
AVG Volume (30 Days)
★ 204.3K
87.1K
Earning Date
11-02-2026
10-29-2026
Dividend Yield
N/A
★ 1.34%
EPS Growth
★ 128.00
N/A
EPS
3.62
★ 27.14
Revenue
$389,130,000.00
★ $2,725,169,000.00
Revenue This Year
$31.33
N/A
Revenue Next Year
$27.55
N/A
P/E Ratio
$93.08
★ $33.35
Revenue Growth
★ 33.94
N/A
52 Week Low
$179.16
$580.03
52 Week High
$382.54
$981.66

Technical Indicators

Market Signals
Indicator
KRYS
NEU
Relative Strength Index (RSI) 41.98 52.90
Support Level $331.79 $833.43
Resistance Level $371.16 $915.07
Average True Range (ATR) 9.85 20.32
MACD -1.37 0.63
Stochastic Oscillator 17.44 63.06

Price Performance

Historical Comparison
KRYS
NEU

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.

Share on Social Networks: